{
    "ticker": "ALTM",
    "name": "Altamira Therapeutics Ltd.",
    "description": "Altamira Therapeutics Ltd. is a biopharmaceutical company focused on developing innovative therapies for the treatment of various diseases with high unmet medical needs. Established in 2018, the company is headquartered in Zug, Switzerland, and is committed to advancing the field of therapeutics through its proprietary platform technologies. Altamira is primarily engaged in the development of RNA-based therapeutics and drug delivery systems, aiming to improve the efficacy and safety of treatments. Their flagship product candidates are designed to address conditions such as neurodegenerative diseases, respiratory disorders, and other inflammatory diseases. Altamira's approach utilizes cutting-edge science, including the latest advancements in RNA technology, to create targeted therapies that can significantly enhance patient outcomes. In addition to its internal development programs, the company is also open to collaborations and partnerships that can accelerate the development of its innovative therapies. The dedicated team at Altamira consists of experienced professionals with a strong background in drug development, regulatory affairs, and commercialization, all working towards a common goal of transforming the treatment landscape for patients globally. Altamira Therapeutics is committed to maintaining the highest standards of ethical practices in drug development and strives to deliver safe and effective therapies for patients in need.",
    "industry": [
        "Biopharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Zug, Switzerland",
    "founded": "2018",
    "website": "https://www.altamiratherapeutics.com",
    "ceo": "Thomas Meyer",
    "social_media": {
        "twitter": "https://twitter.com/AltamiraThera",
        "linkedin": "https://www.linkedin.com/company/altamira-therapeutics-ltd"
    },
    "investor_relations": "https://www.altamiratherapeutics.com/investors",
    "key_executives": [
        {
            "name": "Thomas Meyer",
            "position": "CEO"
        },
        {
            "name": "David A. Errington",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "RNA-based Therapeutics",
            "products": [
                "ALT-100",
                "ALT-200"
            ]
        },
        {
            "category": "Drug Delivery Systems",
            "products": [
                "Nanoformulations"
            ]
        }
    ],
    "seo": {
        "meta_title": "Altamira Therapeutics Ltd. | Innovating RNA-based Therapies",
        "meta_description": "Explore Altamira Therapeutics Ltd., a pioneering biopharmaceutical company focused on RNA-based therapeutics and innovative drug delivery systems. Learn about our mission to improve patient outcomes.",
        "keywords": [
            "Altamira Therapeutics",
            "RNA Therapeutics",
            "Biopharmaceuticals",
            "Drug Delivery",
            "Healthcare Innovation"
        ]
    },
    "faq": [
        {
            "question": "What does Altamira Therapeutics specialize in?",
            "answer": "Altamira Therapeutics specializes in RNA-based therapeutics and innovative drug delivery systems."
        },
        {
            "question": "Who is the CEO of Altamira Therapeutics?",
            "answer": "Thomas Meyer is the CEO of Altamira Therapeutics Ltd."
        },
        {
            "question": "Where is Altamira headquartered?",
            "answer": "Altamira is headquartered in Zug, Switzerland."
        },
        {
            "question": "What are Altamira's main product candidates?",
            "answer": "Altamira's main product candidates include ALT-100 and ALT-200."
        },
        {
            "question": "When was Altamira Therapeutics founded?",
            "answer": "Altamira Therapeutics was founded in 2018."
        }
    ],
    "competitors": [
        "MRNA",
        "ALNY",
        "PFE",
        "BMY"
    ],
    "related_stocks": [
        "JNJ",
        "GILD",
        "AMGN",
        "ABBV"
    ]
}